Pascale Varlet
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 300 publications
Immunohistochemistry as a tool for identifying PDGFRA amplification in central nervous system tumors.
Journal: Brain pathology (Zurich, Switzerland)
Published: July 11, 2026
Desmoplastic myxoid tumor, SMARCB1-mutant: a case with late recurrence after long-term follow-up.
Journal: Free neuropathology
Published: June 06, 2026
Glioneuronal Tumour With Neurocytic Differentiation (GNTN): a Molecularly Defined Tumour Type Formerly Referred to as Extraventricular Neurocytoma.
Journal: Neuropathology and applied neurobiology
Published: April 20, 2026
Intrinsic pontine tumors: Pathology of brainstem tumors and exploration of diffuse intrinsic pontine glioma.
Journal: Handbook of clinical neurology
Published: March 27, 2026
Ovarian central nervous system-type tumors: integrated neuropathological and methylation-based classification reveals site-related features.
Journal: Acta neuropathologica communications
Published: February 22, 2026
New Observations on a Low-Grade Diffusely Infiltrative Tumour, SMARCB1 Mutant, Arguing for a New Tumour Type.
Journal: Neuropathology and applied neurobiology
Published: January 29, 2026
Distinct molecular subgroups in pediatric and young-onset meningiomas require age-adapted risk stratification.
Journal: Nature communications
Published: January 09, 2026
CNS tumor type prevalence according to age group: An analysis of 21 000 cases confirmed by methylation profiling, with a focus on adolescents and young adults.
Journal: Neuro-oncology
Published: January 02, 2026
H3K27ME3 loss in diffuse midline gliomas lacking H3K27M or EZHIP expressions, a potential diagnostic pitfall!
Journal: Acta neuropathologica
Published: December 23, 2025
Usefulness OF SOX10 immunohistochemistry for subtyping diffuse midline gliomas EGFR-altered.
Journal: Acta neuropathologica communications
Published: November 15, 2025
Last Updated: 09/26/2026